Chavibetol corrects thyrotoxicosis through alterations in thyroid peroxidase.

Area of Science:

• Endocrinology
• Pharmacology
• Natural Product Chemistry

Background:

• Thyrotoxicosis, characterized by excess thyroid hormones, impacts multiple organ systems and requires effective treatment.
• Piper betel leaf contains bioactive compounds with potential therapeutic applications.

Purpose of the Study:

• To investigate the ameliorative effects of chavibetol (CHV), isolated from Piper betel leaf, on experimentally induced thyrotoxicosis in rats.
• To compare the efficacy of chavibetol with a conventional antithyroid drug, propylthiouracil (PTU).

Main Methods:

• Rats were induced with thyrotoxicosis using L-thyroxine (L-T4).
• Chavibetol was administered orally to thyrotoxic rats for two weeks.
• Biochemical markers, including thyroid hormones, liver enzymes, antioxidant status, and thyroid peroxidase (TPO) expression, were analyzed.

Main Results:

• L-T4 administration significantly altered thyroid hormone levels, liver enzyme activities, TPO expression, and antioxidant status.
• Chavibetol treatment normalized most of these altered parameters in thyrotoxic rats.
• Chavibetol preserved the histological integrity of thyroid tissues.

Conclusions:

• Chavibetol demonstrates significant potential in correcting thyrotoxicosis by normalizing physiological and biochemical abnormalities.
• The compound's effects were comparable to those of propylthiouracil, suggesting its viability as an alternative therapeutic agent.